Closing a loophole in the FDA Amendments Act (original) (raw)

This paper discusses the implications of a recent discovery regarding aggregate genomic data, particularly in the context of forensics and genomewide association studies (GWAS). The study highlights a new statistical method that can resolve individual genotypes from aggregate data, raising concerns about the privacy and security of such data. In response to these findings, the NIH has altered its policies to restrict access to aggregate genomic data, removing it from public databases to prevent potential misuse.